5th Childhood Diabetes Prevention Symposium 

General Population Screening for T1D

November 11th, 2022 8:00 AM

 


 

Keynote: Francisco Leon - Click here for slides

8:00-8:20 KEYNOTE LECTURE: Targeting the autoimmune origins of type 1 diabetes - Click here for video 

 


 

SESSION 1: IMMUNE MARKERS (Chair: Liping Yu)

 

8:20-8:40 Confirmation of positive screening for autoantibodies: how urgent and what tests to use? - Click here for video 

Kimber Simmons - Click here for slides 

 

8:40-9:00 The TrialNet T1D at risk registry and cross assay comparative results

Jeffrey Krischer

 

9:00-9:15 Session 1 Q & A - Click here for video 


 

SESSION 2:  MARKERS OF DYSGLYCEMIA & EARLY DIABETES EDUCATION (Chair: Andrea Steck)

 

9:15-9:35 The value of A1c and OGTT in predicting progression to clinical T1D - Click here for video

Kendra Vehik - Click here for slides

 

9:35-9:55 The value of CGM in predicting progression to clinical T1D - Click here for video

Andrea Steck - Click here for slides 

 

9:55-10:15 The Early Start Study - Click here for video 

Brigitte Frohnert - Click here for slides 

 

10:15-10:30 Session 2 Q & A - Click here for video 


 

SESSION 3:  PSYCHOSOCIAL ASPECTS OF SCREENING AND MONITORING (Chair: Judith Baxter)

 

10:45-11:05 Child/parental anxiety and risk perception - Click here for video 

Cristy Geno Rasmussen - Click here for slides

 

11:05-11:25 Practical strategies to increase engagement - Click here for video 

Holly O’Donnell - Click here for slides 

 

11:25-11:45 TEDDY/DAISY/ASK experience - Click here for video 

Patricia Gesualdo/ Michelle Hoffman/ Kimberly Bautista - Click here for slides 

 

11:45-12:00 Session 3 Q & A - Click for Video 


 

SESSION 4:  REPORTS FROM ONGOING SCREENING PROGRAMS (Chair: Jessica Dunne)

 

12:30-12:45 Finland - Screening programs for T1D - Click here for video 

Riitta Veijola - Click here for slides 

 

12:45-1:00 Sweden -TRIAD- Click here for video 

Daniel Agardh - Click here for slides 

 

1:00-1:15   The U.K. – ELSA - Click here for video 

Parth Narendran - Click here for slides 

 

1:15-1:30  USA, Virginia – PriMed - Click here for video 

Stephen Rich - Click here for slides 

 

1:30-1:45   JDRF T1Detect - Click here for video 

Esther Latres - Click here for slides 

 

1:45-2:00 Session 4 Q & A - Click for video 


 

SESSION 5:  NEW CHALLENGES (Chair: Aaron Michels)

 

2:15-2:35 Integration of screening/monitoring with routine care and EHR in PLEDGE - Click here for video

Kurt Griffin - Click here for slides

 

2:35-3:00 Optimal ages to screen. CASCADE project - Click here for video 

William Hagopian/Mohamed Ghalwash - Click here for slides 

 

3:00-3:10 Screening general population adults for islet autoantibodies - Click here for video 

Meghan Pauley - Click here for slides 

 

3:10-3:30 Cost-effectiveness of screening - Click here for video 

R Brett McQueen - Click here for slides 

 

3:30-3:45 Session 5 Q &A - Click for video 


 

SPECIAL VIRTUAL SESSION: Current Status of General Population Screening Programs

 

Slides not presented in person during the main program (click to open)

Germany: Fr1da (Anette-Gabriele Ziegler)

USA, Colorado: ASK (Marian Rewers)

USA: ASK the Experts (Kimber Simmons)

Israel: ADIR (Tal Oron)

Australia: National Screening Pilot (Kirstine Bell)

 

Barbara Davis Center (SOM)

CU Anschutz

Barbara Davis Center for Diabetes

1775 North Aurora Court

Aurora, CO 80045


303-724-2323

CMS Login